The global Liver Biopsy Market is touted to grow at a CAGR of 4.2% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in a minutely analyzed research report. Increase in the occurrence of liver disorders has been the main driving force behind the growth of the market. Liver infection is widespread these days which raises the demand for diagnosis and is well complemented by growing awareness towards early diagnosis of liver diseases. Advancements in medical technology have presented new approaches to performing liver biopsy which is less invasive or non-invasive which spurs the growth of the global liver biopsy market.
Increase in the prevalence of diabetes and obesity among the global population has also contributed to the market growths in diabetes and obesity expose patients to higher risks of acquiring liver diseases which induce demand for liver biopsy. The emergence of biomarkers, improvement in liver biopsy technologies, and the rise in number of FDA approvals for new biopsy devices are other driving factors. Conversely, the high cost of diagnostic devices is expected to hamper the growth of the global liver biopsy market over the forecast period. Side effects and complications post liver biopsy is also a major impediment to the market growth.
Liver Biopsy Market Segmentation
The global liver biopsy market has been segmented based on
- End user
By Type, the liver biopsy market has been segmented into
- Trans jugular
- Laparoscopic biopsy
By indication, the liver biopsy market has been segmented into
- Nonalcoholic fatty liver disease
- Chronic hepatitis B or C
- Autoimmune hepatitis
- Alcoholic liver disease
By end user, the liver biopsy market has been segmented into
- Tertiary Care Centers
- Urology Centers
Liver Biopsy Market Regional Analysis
High prevalence of chronic liver diseases which induces demand for diagnostic services, availability of funds for R&D activities and the emergence of new market players in the region can be attributed for the growth of the Europe liver biopsy market. Asia Pacific market is expected to expand at a relatively faster rate than others owing to the rapidly developing healthcare sector in the fast-developing countries such as India, Japan, and China coupled with high prevalence of liver disorders in the region. Also, increasing healthcare expenditure and government support for research supports liver biopsy market expansion. Furthermore, towering demand for advanced quality diagnosis devices is expected to speed up the growth of the market. The Middle East & Africa market holds the least share of the global market. The Africa region is expected to exhibit limited growth due to limited availability of medical facilities while the United Arab Emirates, Saudi Arabia, and Kuwait are estimated to drive the Middle East market.
Liver Biopsy Market Competitive Landscape
The prominent players operating in the global liver biopsy market include
- Veran medical
- Intact Medical Corp.
- Argon Medical Devices, Inc.
- INRAD Inc.
- Hologic Inc.,
- Mauna Kea Technologies
- Cook Medical
- Leica Biosystems
- Fujifilm Medical Systems
- Boston Scientific Corporation
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.